ArticleTargeted oncology2019

Acquired EGFR L718V Mutation as the Mechanism for Osimertinib Resistance in a T790M-Negative Non-Small-Cell Lung Cancer Patient.

Zhe Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.